• Users Online: 1075
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
RESEARCH ARTICLE
Year : 2022  |  Volume : 59  |  Issue : 2  |  Page : 172-177

Seroprevalence against Toscana virus in Spain: The case of the autonomous community of Madrid


1 Area of Microbiology, Hospital Universitario de Fuenlabrada, Cº Molino, 2. 28942-Fuenlabrada, Madrid, Spain
2 Rey Juan Carlos University, Av. Atenas s/n. 28922, Alcorcón, Madrid, Spain
3 Area of Preventive Medicine and Public Health, Rey Juan Carlos University, Av. Atenas s/n. 28922, Alcorcón, Madrid, Spain
4 Area of Haematology, Hospital Universitario de Fuenlabrada, Cº Molino, 2. 28942-Fuenlabrada, Madrid, Spain
5 Area of Medical Immunology, Rey Juan Carlos University, Av. Atenas s/n. 28922, Alcorcón, Madrid, Spain
6 Area of Medical Microbiology, Rey Juan Carlos University, Av. Atenas s/n. 28922, Alcorcón, Madrid, Spain

Correspondence Address:
Alba González-Escalada
Area of Medical Microbiology, Rey Juan Carlos University, Av. Atenas s/n. 28922, Alcorcón, Madrid
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-9062.335771

Rights and Permissions

Background & objectives: The Toscana virus (TOSV) is a neurotropic arbovirus that is transmitted through the bite of some Phlebotomus species. In 2009, the largest outbreak of leishmaniasis described so far in Europe, occurred in the Autonomous Community of Madrid, Spain, which was related to the population increase of P. perniciosus in this region. Methods: A seroprevalence study was conducted to determine the circulation of TOSV among the population of this geographic area. A total of 516 sera were collected in two different stages: 2007 (before the leishmaniasis outbreak) and 2018–19 (representative of the current situation). In the sera, presence of IgG antibodies against TOSV was determined by commercial ELISA. Results: The overall seroprevalence was 34.5%. The anti-TOSV IgG level was significantly higher in the samples collected in 2007 (41.5%) than 2018–19 (27.3%). Interpretation & conclusion: The results of this study show a very active TOSV circulation in the region that is greater than expected. The lower seroprevalence figures in 2018–19 may be related to the vector and environmental control measures that were put in place as a result of the leishmaniasis outbreak of 2009. This highlights the importance of such strategies to reduce the incidence of TOSV infection and other vector-borne diseases.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed678    
    Printed6    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal